A case of diverticular colitis with lesions resembling ulcerative colitis and correlation of tumor necrosis factor-alpha staining with clinical manifestations

被引:2
|
作者
Torii Y. [1 ]
Katano Y. [1 ]
Yoshino J. [1 ]
Inui K. [1 ]
Wakabayasi T. [1 ]
Kobayashi T. [1 ]
Kosaka T. [1 ]
机构
[1] Department of Internal Medicine, Banbuntane-Houtokukai Hospital, Fujita Health University School of Medicine, 3-6-10 Otobashi, Nakagawa-ku, Nagoya
关键词
Anti-TNA-α; antibody; Diverticular colitis; Inflammatory bowel disease;
D O I
10.1007/s12328-015-0608-5
中图分类号
学科分类号
摘要
A 45-year-old male with a 3-month history of abdominal pain and melena underwent colonoscopy (CS) at our hospital in May 2009. He was diagnosed with diverticular colitis based on findings of redness around diverticula in the sigmoid colon and biopsy findings of non-specific inflammation. The second CS, which was performed in July 2009 to investigate relapse, showed diffuse redness around diverticula in the sigmoid colon. As seen in active ulcerative colitis (UC), the formation of crypt abscesses was observed in the biopsy. Although the patient was making satisfactory progress after administration of oral mesalazine, CS was performed again in September 2011 because of recurrence of melena, which revealed redness and erosion around diverticula in the ascending and sigmoid colon. Biopsy findings were similar to those of active UC. Immunohistochemical staining of the biopsy specimen with anti-tumor necrosis factor (TNF)-α antibody showed 80 % of lymphocytes were positive for TNF-α compared with 20 % at the first biopsy. The patient’s symptoms subsided with an increase in the dose of mesalazine and concurrent administration of prednisolone at 10 mg. He has remained on oral mesalazine and is currently asymptomatic. The findings of this study suggested a correlation between clinical manifestations and the proportion of TNF-α-positive lymphocytes. © 2015, Japanese Society of Gastroenterology.
引用
收藏
页码:377 / 384
页数:7
相关论文
共 50 条
  • [21] Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
    Sophie E. Berends
    Tamara J. van Steeg
    Maurice J. Ahsman
    Sharat Singh
    Johannan F. Brandse
    Geert R. A. M. D’Haens
    Ron A. A. Mathôt
    Journal of Pharmacokinetics and Pharmacodynamics, 2019, 46 : 543 - 551
  • [22] Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
    Berends, Sophie E.
    van Steeg, Tamara J.
    Ahsman, Maurice J.
    Singh, Sharat
    Brandse, Johannan F.
    D'Haens, Geert R. A. M.
    Mathot, Ron A. A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (06) : 543 - 551
  • [23] Splenic abscess in ulcerative colitis under anti tumor necrosis factor treatment
    Akpinar, Muhammet Yener
    Oztas, Erkin
    Coskun, Orhan
    Yalinkilic, Zeki Mesut
    Kuzu, Ufuk Baris
    Kayacetin, Ertugrul
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2015, 78 (02): : 252 - 252
  • [24] Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
    Su, CY
    Salzberg, BA
    Lewis, JD
    Deren, JJ
    Kornbluth, A
    Katzka, DA
    Stein, RB
    Adler, DR
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2577 - 2584
  • [25] Prediction of clinical and endoscopic responses to anti-tumor necrosis factor- antibodies in ulcerative colitis
    Morita, Yukihiro
    Bamba, Shigeki
    Takahashi, Kenichiro
    Imaeda, Hirotsugu
    Nishida, Atsushi
    Inatomi, Osamu
    Sasaki, Masaya
    Tsujikawa, Tomoyuki
    Sugimoto, Mitsushige
    Andoh, Akira
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (08) : 934 - 941
  • [26] COLONIC ORGANOIDS AS A MODEL TO INVESTIGATE CLINICAL RESPONSIVENESS TO ANTI-TUMOR NECROSIS FACTOR IN ULCERATIVE COLITIS
    Axelrad, Jordan E.
    Jang, Kyung Ku
    Hine, Ashley M.
    Cadwell, Ken
    GASTROENTEROLOGY, 2020, 158 (06) : S1037 - S1038
  • [27] Altered expression of Tumor Necrosis Factor Alpha -Induced Protein 3 correlates with disease severity in Ulcerative Colitis
    Ishani Majumdar
    Vineet Ahuja
    Jaishree Paul
    Scientific Reports, 7
  • [28] Altered expression of Tumor Necrosis Factor Alpha -Induced Protein 3 correlates with disease severity in Ulcerative Colitis
    Majumdar, Ishani
    Ahuja, Vineet
    Paul, Jaishree
    SCIENTIFIC REPORTS, 2017, 7
  • [29] Tumor necrosis factor-alpha and interleukin 6 in human periapical lesions
    Prso, Ivana Brekalo
    Kocjan, Willy
    Simic, Hrvoje
    Brumini, Gordana
    Pezelj-Ribaric, Sonja
    Borcic, Josipa
    Ferreri, Silvio
    Karlovic, Ivana Miletic
    MEDIATORS OF INFLAMMATION, 2007, 2007
  • [30] SYSTEMIC TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION IN EXPERIMENTAL COLITIS
    MACK, DR
    LAU, AS
    SHERMAN, PM
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (11) : 1738 - 1745